|
A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced NET of GI or Lung Origin - RADIANT-4
|
Ongoing
|
Everolimus/ Afinitor
|
3
|
CRAD001T2302
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A 24 month, randomized, controlled, study to evalute the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus in recipients of living donor liver transplants.
|
Ongoing
|
Everolimus / reduced tacrolimus / Tacrolimus
|
3
|
CRAD001H2307
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
An Open-lable, Multicenter, Phase 2 Study to Evaluate Everolimus as Monotherapy Treatment for patients with Metastatic Recurrent and/or Unresectable Renall Cell Carcinoma (EVERMORE).
|
Ongoing
|
Everolimus
|
2
|
CRAD001LIC01
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
An Open-lable, Multicenter, expanded access study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrosis (PET-MF).
|
Ongoing
|
Ruxolitinib
|
3b
|
CINC424A2401
|
King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)
|
|
A Phase III, Multicenter, Randomized, parallel-group study to asses the efficacy and saftey of double-blind pasireotide LAR 40 mg and pasireotide LAR 60 mg versus open lable octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly.
|
Ongoing
|
Pasireotide
|
3
|
CSOM230C2402
|
King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Jeddah)
|
|
A Randomized, Open-label, Multicentral, Two Arm, Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)
|
Ongoing
|
Deferasirox / Defearisox new formula
|
2
|
CICL670F2201
|
King Khalid University Hospital (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz University Hospital (Jeddah), King Fahad Specialist Hospital (Dammam)
|
|
Daily practice treatment and Influence of Visanne on the patient Assessment of quality of life parameters
|
Completed
|
Visanne
|
4
|
VS1101
|
King Khalid University Hospital (Riyadh), Soliman Fakeeh Hospital (Jeddah)
|
|
A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin
|
Completed
|
BIAsp 30 / Metformin
|
4
|
BIAsp 3968
|
King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz University Hospital (Jeddah), Armed Forces Hospital (Al-Hada)
|
|
An Open-Label, Randomized Naturalistic Study to Evaluate the Incidence of Hypoglycemia Comparing Sitagliptin With Sulfonylurea Treatment in Patients With Type 2 Diabetes During Ramadan Fasting
|
Completed
|
Sitagliptin
|
4
|
MK0431-263
|
Al-Noor Specialist Hospital (Makkah), Armed Forces Hospital (Al-Hada), King Fahad University Hospital (Al-Khobar), Riyadh Care Hospital, Al Alam Medical Center (Riyadh)
|
|
A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating On-Treatment Predictors of Response in Subjects With HBeAg Positive and HBeAg Negative Chronic Hepatitis B Receiving Therapy With PEGASYS(R) (Peginterferon Alfa-2a 40KD)
|
Completed
|
Pegasys
|
4
|
MV22009
|
King Fahad University Hospital (Al-Khobar), Armed Forces Hospital (Kharj)
|
